相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in Autophagic Response in Patients with Chronic Hepatitis C Virus Infection
Pierre-Emmanuel Rautou et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Recruitment and Activation of a Lipid Kinase by Hepatitis C Virus NS5A Is Essential for Integrity of the Membranous Replication Compartment
Simon Reiss et al.
CELL HOST & MICROBE (2011)
Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection
Stefan Zeuzem et al.
GASTROENTEROLOGY (2011)
Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3
Harshna Patel et al.
GUT (2011)
Treatment Failure and Resistance with Direct-Acting Antiviral Drugs Against Hepatitis C Virus
Jean-Michel Pawlotsky
HEPATOLOGY (2011)
Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro
Po-Yuan Ke et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
NS5A inhibitors: A new breakthrough for the treatment of chronic hepatitis C
Tarik Asselah
JOURNAL OF HEPATOLOGY (2011)
Activation of unfolded protein response and autophagy during HCV infection modulates innate immune response
Emilie Estrabaud et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis C virus resistance to protease inhibitors
Philippe Halfon et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
Mirjam B. Zeisel et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis C Virus Stimulates the Phosphatidylinositol 4-Kinase III Alpha-Dependent Phosphatidylinositol 4-Phosphate Production That Is Essential for Its Replication
Kristi L. Berger et al.
JOURNAL OF VIROLOGY (2011)
New direct-acting antivirals' combination for the treatment of chronic hepatitis C
Tarik Asselah et al.
LIVER INTERNATIONAL (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex
Erica S. Machlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Assembly of infectious hepatitis C virus particles
Ralf Bartenschlager et al.
TRENDS IN MICROBIOLOGY (2011)
A Concerted Action of Hepatitis C Virus P7 and Nonstructural Protein 2 Regulates Core Localization at the Endoplasmic Reticulum and Virus Assembly
Bertrand Boson et al.
PLOS PATHOGENS (2011)
NEW HEPATITIS C THERAPIES IN CLINICAL DEVELOPMENT
Johannes Vermehren et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2011)
Cyclophilin D is required for mitochondrial removal by autophagy in cardiac cells
Raquel S. Carreira et al.
AUTOPHAGY (2010)
New NS5B polymerase inhibitors for hepatitis C
Florence Legrand-Abravanel et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Hepatitis C Virus Non-structural Protein 3 (HCV NS3): A Multifunctional Antiviral Target
Kevin D. Raney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors
Udayan Chatterji et al.
JOURNAL OF HEPATOLOGY (2010)
RG7128 Alone or in Combination with Pegylated Interferon-α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV-Infected Patients
Sophie Le Pogam et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C
Tarik Asselah et al.
JOURNAL OF PATHOLOGY (2010)
Identification of Hepatitis C Virus NS5A Inhibitors
Julie A. Lemm et al.
JOURNAL OF VIROLOGY (2010)
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
Edward J. Gane et al.
LANCET (2010)
Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin
Tarik Asselah et al.
LIVER INTERNATIONAL (2010)
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
Min Gao et al.
NATURE (2010)
Telaprevir for Previously Treated Chronic HCV Infection.
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
New Insights into Structure and Replication of the Hepatitis C Virus and Clinical Implications
Marion Poenisch et al.
SEMINARS IN LIVER DISEASE (2010)
An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C
Raf Crabbe et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening
Maud Trotard et al.
FASEB JOURNAL (2009)
Cyclosporine A Inhibits Hepatitis C Virus Nonstructural Protein 2 Through Cyclophilin A
Sandra Ciesek et al.
HEPATOLOGY (2009)
Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B
Xavier Hanoulle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication
Jason Borawski et al.
JOURNAL OF VIROLOGY (2009)
Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication
Kristi L. Berger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication
Frederic H. Vaillancourt et al.
VIROLOGY (2009)
Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
Artur Kaul et al.
PLOS PATHOGENS (2009)
Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations
Thomas Pietschmann et al.
PLOS PATHOGENS (2009)
RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis
Kelly E. Coller et al.
PLOS PATHOGENS (2009)
Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome
Catherine L. Jopling et al.
CELL HOST & MICROBE (2008)
microRNA-122 stimulates translation of hepatitis C virus RNA
Jura Inga Henke et al.
EMBO JOURNAL (2008)
Hepatitis C virus entry: possible targets for therapy
J. M. Timpe et al.
GUT (2008)
The cyclophilin inhibitor debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus
Robert Flisiak et al.
HEPATOLOGY (2008)
Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly
Vlastimil Jirasko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro
Feng Yang et al.
JOURNAL OF VIROLOGY (2008)
Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis
Shirit Einav et al.
NATURE BIOTECHNOLOGY (2008)
Phenotypic and structural analyses of hepatitis C virus NS3 protease Arg155 variants -: Sensitivity to telaprevir (VX-950) and interferon α
Yi Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture
Ralf Bartenschlager et al.
VIRUS RESEARCH (2007)
Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus
Christopher T. Jones et al.
JOURNAL OF VIROLOGY (2007)
Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions
Eike Steinmann et al.
PLOS PATHOGENS (2007)
Hepatitis C virus entry depends on clathrin-mediated endocytosis
Emmanuelle Blanchard et al.
JOURNAL OF VIROLOGY (2006)
Viral hepatitis and liver cancer: the case of hepatitis C
M. Levrero
ONCOGENE (2006)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
TL Tellinghuisen et al.
NATURE (2005)
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
T Kato et al.
GASTROENTEROLOGY (2003)
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
D Lamarre et al.
NATURE (2003)
The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine
SDC Griffin et al.
FEBS LETTERS (2003)
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
K Watashi et al.
HEPATOLOGY (2003)
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication
KJ Blight et al.
JOURNAL OF VIROLOGY (2002)
Persistent and transient replication of full-length hepatitis C virus genomes in cell culture
T Pietschmann et al.
JOURNAL OF VIROLOGY (2002)
分享论文
